Literature DB >> 3067492

Predeposit autologous blood donation.

L Stehling1.   

Abstract

Predeposit autologous donation for elective surgical procedures during which there is a potential requirement for transfusion is medically proven as safe and efficacious but significantly underutilized. The primary advantages are avoidance of transfusion-transmitted disease and alloimmunization. Appropriate donor selection is essential. In general, there are no age or weight limits for donors. The incidence of adverse reactions is no greater in properly selected autologous donors than in homologous donors. Administration of oral ferrous sulfate allows many patients to meet all of their perioperative transfusion requirements. The blood is usually stored in the liquid state, but can be frozen. The mere availability of autologous blood is not an indication for its reinfusion. The criteria for transfusion are similar to those for homologous blood. However, a more liberal interpretation may be appropriate in some clinical situations. The issue of disposition of predonated blood which is not transfused to donor-patients remains unresolved. In some areas all units are discarded. In others, the blood can be administered to other patients if the donor met all the criteria for homologous donors and the blood tested negative for infectious disease markers.

Entities:  

Mesh:

Year:  1988        PMID: 3067492     DOI: 10.1111/j.1399-6576.1988.tb02845.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand Suppl        ISSN: 0515-2720


  1 in total

1.  Patient blood management in a neurosurgical patient with anti-e antibody.

Authors:  Sreethu Chand; Anila Mani; R Amita; Debasish Gupta
Journal:  Asian J Transfus Sci       Date:  2021-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.